Related Experiment Video
Updated: Jun 21, 2026

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
Published on: July 9, 2012
Resistance against broad-spectrum beta-lactams among uropathogens in children
Maria Bitsori1, Sofia Maraki, Maria Kalmanti
1Department of Paediatrics, University Hospital of Heraklion, POB 1352, Heraklion 71500, Greece. bitmar@hol.gr
Insights
Urinary tract infections (UTIs) caused by broad-spectrum beta-lactam resistant Enterobacteriaceae are increasing in children. Risk factors include male gender, urinary abnormalities, and prior antibiotic use, limiting treatment options.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Resistance
- Clinical Microbiology
Background:
- Urinary tract infections (UTIs) are common in children.
- The rise of antimicrobial resistance poses a significant threat to effective treatment.
- Enterobacteriaceae are frequent causes of UTIs, and resistance to broad-spectrum beta-lactams is a growing concern.
Purpose of the Study:
- To investigate the prevalence trends of Enterobacteriaceae resistant to broad-spectrum beta-lactams in pediatric UTIs.
- To identify risk factors associated with these resistant infections.
- To understand the implications for antibiotic treatment and prophylaxis strategies.
Main Methods:
- Retrospective analysis of Enterobacteriaceae isolates from children under 15 years old.
- Data collected over an 11-year period (1997-2007).
- Phenotypic resistance testing and evaluation of clinical risk factors.
Main Results:
- Prevalence of resistance to broad-spectrum beta-lactams among Enterobacteriaceae increased significantly over the study period (p = 0.031).
- Of 523 isolates, 30 (5.73%) were resistant; common species included Escherichia coli and Klebsiella spp.
- Resistant infections were frequently community-acquired (73.3%) and associated with male gender, urinary tract abnormalities, prophylactic antibiotics, longer hospitalization, and recurrent UTIs.
Conclusions:
- There is an increasing prevalence of community-acquired Enterobacteriaceae resistant to broad-spectrum beta-lactams in children.
- This resistance limits the effectiveness of first-line antibiotics for UTIs.
- The findings question the routine use of antibiotic prophylaxis after a first UTI episode due to the risk of selecting for resistant organisms.
Abstract:
The aim of this study was to investigate the prevalence trends and risk factors for urinary tract infection (UTI) caused by Enterobacteriaceae resistant to broad-spectrum beta-lactams in children. All Enterobacteriaceae uropathogens from children <15 years during the 11-year period 1997-2007 were included, and risk factors were evaluated. Of 523 Enterobacteriaceae isolated from 473 children, 30 (5.73%) were phenotypically resistant to broad-spectrum beta-lactams (18 Escherichia coli, ten Klebsiella spp, one Enterobacter spp, and one Citrobacter spp). The prevalence of resistance increased during the study period (p = 0.031). Resistance to cefoxitin was common (26/30), pointing to AmpC enzyme expression, and 2/30 isolates were resistant to carbapenems. Resistant Enterobacteriaceae were often community acquired (22/30, 73.3%) and related to male gender (p < 0.05), urinary tract abnormalities (p < 0.05), prophylactic antibiotics (p < 0.0001), longer hospitalization (p < 0.001), and UTI recurrences (p < 0.001). Co-resistance was more likely for cotrimoxazole, gentamicin, and ciprofloxacin (p < 0.0001). In conclusion, our study points to increasing prevalence of Enterobacteriaceae uropathogens resistant to broad-spectrum beta-lactams in the community setting, which limits the utility of first-line antibiotics and questions the validity of using prophylaxis after a first UTI episode.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Urine Studies II: Urine Culture and Sensitivity Test
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
